netFormulary NHS
Bedfordshire and Luton Joint Formulary
Bedford Hospital NHS Trust
Bedfordshire CCG
Luton & Dunstable University Hospital NHS Foundation Trust
Luton CCG
 Search
 Formulary Chapter 13: Skin - Full Chapter
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

Chapter Links...
 Details...
13.08  Expand sub section  Sunscreens and camouflagers
13.08.01  Expand sub section  Sunscreen preparations
Uvistat®SPF30
(Cream)
View adult BNF View SPC online View childrens BNF
First Choice
Amber

N.B. Must write 'ACBS' on FP10 borderline substance.

May be prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures

 
Anthelios XL®
(Melt in cream)
View adult BNF View SPC online View childrens BNF
Second Choice
Amber

N.B. Must write 'ACBS' on FP10 borderline substance.

May be prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures

 
   
Sunsense® Ultra
(Lotion)
View adult BNF View SPC online View childrens BNF
Second Choice
Amber

SPF 50+ roll-on or bottle pump.

N.B. Must write 'ACBS' on FP10 borderline substance.

May be prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures

 
   
5-aminolaevulinic acid (Ameluz®)
(Gel)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

For use with photodynamic therapy (PDT) in Dermatology

 
   
13.08.01  Expand sub section  Photodamage
Cytotoxic Drug Fluorouracil 5% (Efudix®)
(Cream)
View adult BNF View SPC online View childrens BNF
Formulary
Amber
 
   
Ingenol mebutate (Picato®)
(Gel)
View adult BNF View SPC online View childrens BNF
Formulary
Red

The Marketing Authorisation for Picato has been suspended whilst the concerns on the possible risk of skin malignancy are investigated.

 
Link  MHRA Drug Safety Update: Ingenol mebutate gel (Picato„): suspension of the licence due to risk of skin malignancy (February 2020)
Link  MHRA Drug Safety Update: Ingenol mebutate gel (Picato„): increased incidence of skin tumours seen in some clinical studies (October 2019)
   
13.08.02  Expand sub section  Camouflagers
Covermark®
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Classic Foundation

Prior to prescribing, self-care options should be considered.
If NHS Prescribing is required, the following recommendations apply:-
 The prescribing of camouflage creams by clinicians is only supported if the patient has a disfiguring facial condition that is causing distress, impacting in a restrictive way on the patient’s life.
Prior to prescribing:-
 The patient should be referred to a Secondary Care Specialist for advice on optimal management and investigation of any underlying cause.
 The patient should be referred to a trained skin camouflage practitioner for colour matching.

 
Link  JPC Guidance for the Prescribing of Camouflage Creams in Primary Care. Bulletin 273
   
Dermacolor®
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Camouflage cream

Prior to prescribing, self-care options should be considered.
If NHS Prescribing is required, the following recommendations apply:-
 The prescribing of camouflage creams by clinicians is only supported if the patient has a disfiguring facial condition that is causing distress, impacting in a restrictive way on the patient’s life.
Prior to prescribing:-
 The patient should be referred to a Secondary Care Specialist for advice on optimal management and investigation of any underlying cause.
 The patient should be referred to a trained skin camouflage practitioner for colour matching.

 
Link  JPC Guidance for the Prescribing of Camouflage Creams in Primary Care. Bulletin 273
   
Keromask®
View adult BNF View SPC online View childrens BNF
Formulary
Amber

Masking Cream

Prior to prescribing, self-care options should be considered.
If NHS Prescribing is required, the following recommendations apply:-
 The prescribing of camouflage creams by clinicians is only supported if the patient has a disfiguring facial condition that is causing distress, impacting in a restrictive way on the patient’s life.
Prior to prescribing:-
 The patient should be referred to a Secondary Care Specialist for advice on optimal management and investigation of any underlying cause.
 The patient should be referred to a trained skin camouflage practitioner for colour matching.

 
Link  JPC Guidance for the Prescribing of Camouflage Creams in Primary Care. Bulletin 273
   
 ....
 Non Formulary Items
Cytotoxic Drug  Actikerall®

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Afamelanotide  (Scenesse®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Aminolevulinic acid

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Borderline Substances  (Delph®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Borderline Substances  (SpectraBan®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Camouflagers  (Dermablend®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Diclofenac  (Solaraze®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Dundee reflective sun creams  (Dundee Block®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fluorouracil  (Actikerall®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Methyl-5-Aminolevulinate  (Metvix®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (Anthelios XL)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (E45 Sun®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sunscreen  (Roc®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Veil®

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment  

Amber

Amber medicines are considered suitable for GP prescribing following specialist initiation.  

Green

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations   

Amber SCG

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.   

Black

A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.   

netFormulary